| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.36 | 0.009 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.34 | 0.008 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |